Comparison of Symptom Severity in Natural and Experimentally Induced Colds
- 1 May 1996
- journal article
- research article
- Published by SAGE Publications in American Journal of Rhinology
- Vol. 10 (3) , 167-172
- https://doi.org/10.2500/105065896781794888
Abstract
Antiviral and symptomatic therapies for the common cold have been evaluated in studies that use either natural colds in the community or colds induced by experimental infection with rhinovirus. The purpose of this study was to compare the severity and natural history of experimentally induced and naturally occurring colds of undetermined etiology. Forty-one subjects with natural colds were compared to 24 subjects with experimental rhinovirus colds. The highest mean daily symptom score, rhinorrhea score, and nasal obstruction score in the natural cold subjects were 14.2, 2.1, and 2.5 respectively. In contrast, the highest mean daily symptom score, rhinorrhea score, and nasal obstruction score in the experimental rhinovirus colds were 9.3, 1.8, and 1.8, respectively (P < 0.005 compared to natural colds). Similarly, the highest mean daily mucus weight in the natural colds, 2.9 gms, was significantly higher than in the experimental colds, 2.3 gms (P = 0.01). There was no significant difference in the lowest mean nasal airflow in the natural and experimental models, .552 l/sec and .508 l/sec, respectively. These results suggest that subjects with natural colds have more severe symptoms than subjects with experimental colds, however, these differences may be due to selection bias inherent in the natural cold study design. Both study designs have potential advantages and selection of the most appropriate design is dependent on the specific aims of the study.Keywords
This publication has 15 references indexed in Scilit:
- Signs and symptoms in common coldsEpidemiology and Infection, 1993
- A double-blind, placebo-controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with the common coldJournal of Allergy and Clinical Immunology, 1992
- Combined Antiviral and Antimediator Treatment of Rhinovirus ColdsThe Journal of Infectious Diseases, 1992
- Intranasal Interferon- 2b for Seasonal Prophylaxis of Respiratory InfectionThe Journal of Infectious Diseases, 1986
- Prevention of Natural Colds by Contact Prophylaxis with Intranasal Alpha2-InterferonNew England Journal of Medicine, 1986
- Prophylactic Efficacy of Intranasal Alpha2-Interferon against Rhinovirus Infections in the Family SettingNew England Journal of Medicine, 1986
- A Model for Obtaining Predictable Natural Transmission of Rhinoviruses in Human VolunteersThe Journal of Infectious Diseases, 1984
- Intranasal Interferon 2 for Prevention of Rhinovirus Infection and IllnessThe Journal of Infectious Diseases, 1983
- Efficacy and Tolerance of Intranasally Applied Recombinant Leukocyte A Interferon in Normal VolunteersThe Journal of Infectious Diseases, 1983
- Transmission of the Common Cold to Volunteers Under Controlled ConditionsA.M.A. Archives of Internal Medicine, 1958